Future studies will require to examine the in vivo survival capacity of hCPCs upon upregulation of CYGB, and conduct a thorough analysis of the molecular mechanisms underlying the potential cytoprotective function of CYGB following acute myocardial infarction. Here, CYGB is linked to myocardial infarction.